Pharmawatch SRL
The score of Pharmawatch shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +20 % Total assets -17 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmawatch's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 30 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 30 Sep 2022filed on 30 May 2023
- Year ended 30 Sep 2021filed on 30 Apr 2022
Pharmawatch's financial analysis
- Solvency82.3%sector median: 58.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmawatch
Pharmawatch's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0544.921.155
- VAT number
- BE0544921155
- Peppol
- Registered · 0208:0544921155 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Jan 2014
- Registered office
- 3700 Tongeren-Borgloon
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Pharmawatch (SRL) has been based in Tongeren-Borgloon since 2014, active in: business and other management consultancy activities. For 2025, it reports a net loss of 30,674 € and equity of 292,868 €; its revenue is not published. Its solvency stands at 82.3%, above the median of its sector (58.9%).
Companies similar to Pharmawatch
Companies in the same business, of comparable size and area, outside its group.
- Boesmanskop Business and other management consultancy activities Ghent · balance sheet 355,905 €
- Adrien Invest Business and other management consultancy activities La Hulpe · balance sheet 355,475 €
- CQM Business and other management consultancy activities Antwerp · balance sheet 355,336 €
- C.C.O. Immo Consult Business and other management consultancy activities Beloeil · balance sheet 354,928 €
- 4Ward Invest Business and other management consultancy activities Gistel · balance sheet 356,841 €
- Sabrit Business and other management consultancy activities Bilzen-Hoeselt · balance sheet 354,775 €
- Erelcom Business and other management consultancy activities Kapellen · balance sheet 357,312 €
- ATMS Business and other management consultancy activities Forest · balance sheet 357,480 €
Frequently asked questions about Pharmawatch
What is the revenue of Pharmawatch?
Pharmawatch files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmawatch?
In Belgium, the VAT number is the company number prefixed with BE: BE0544921155 for Pharmawatch, if the company is VAT-registered. Its company number (CBE) is 0544.921.155.
Where is the registered office of Pharmawatch?
According to the CBE register, the registered office of Pharmawatch is in 3700 Tongeren-Borgloon.
What is the equity of Pharmawatch?
At the close of the 2025 financial year, the equity of Pharmawatch amounts to 292,868 €, a solvency of 82.3% of total assets.
Who manages Pharmawatch?
The register lists 1 active mandates at Pharmawatch. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmawatch
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →